Lv1
46 积分 2024-05-09 加入
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
20天前
已完结
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review
21天前
已完结
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
3个月前
已完结
Anti-PqsR compounds as next-generation antibacterial agents against Pseudomonas aeruginosa: A review
4个月前
已完结
皖公网安备34019202002308
